Trial · NCT02674464
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Controlled Blood Pressure | 12 months | Number of participants with Controlled Blood Pressure (\<140/90 mm Hg). |
| Primary | Patient Activation Measure (PAM-13) | Baseline, 12 months | The Patient Activation Measure assesses knowledge, skills, and confidence in the management of one's health. It is comprised of 13 items and each item is on a 1-5 scale. Insignia health scores on a standardized overall score of 0-100 where higher scores indicate a better outcome. |
| Secondary | Mean Systolic Blood Pressure | Baseline, 12 months | Mean Systolic Blood Pressure in mm Hg at baseline and 12 months. |
| Secondary | Mean Diastolic Blood Pressure | Baseline, 12 months | Mean Diastolic Blood Pressure in mm Hg at baseline and 12 months. |
| Secondary | Change in Global Framingham Risk Score | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean Total Cholesterol (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean LDL-C (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | Change in Mean HDL (mg/dL) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | % With Controlled Total Cholesterol | Baseline | Clinical Outcome |
| Secondary | % With Controlled Total Cholesterol | 12 months | Clinical Outcome |
| Secondary | % With Controlled Total Cholesterol | 24 months | Clinical Outcome |
| Secondary | Change in Mean Glycosylated Hemoglobin (Hemoglobin A1c) | Baseline, 12, 24 months | Clinical Outcome |
| Secondary | % With Hemoglobin A1c< 7.0 | Baseline | Clinical Outcome |
| Secondary | % With Hemoglobin A1c< 7.0 | 12 months | Clinical Outcome |
| Secondary | % With Hemoglobin A1c< 7.0 | 24 months | Clinical Outcome |
| Secondary | Change in Patient Assessment of Care for Chronic Conditions (PACIC-Plus) | Baseline, 12, 24 months | Patient Reported Outcome |
| Secondary | % With BP <140/90 mmHg | 24 months | Clinical Outcome |
| Secondary | % With BP <130/80 mmHg | 12 months | Clinical Outcome |
| Secondary | % With BP <130/80 mmHg | 24 months | Clinical Outcome |
| Secondary | % With BP <120/80 mmHg | 12 months | Clinical Outcome |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02674464/registered